Focus: Spineart is a Switzerland-based medical device company specializing in spinal implants, with a focused product portfolio addressing musculoskeletal disease.
Profile data last refreshed 15h ago · AI intelligence enriched 3w ago
Stable — net +3 jobs in 30d
7 added, 4 removed. Backfill posture.
Spineart is a targeted opportunity for commercial or manufacturing professionals in spinal devices seeking specialization, but limited scale and pipeline depth make it risky for those prioritizing growth visibility or innovation exposure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Spineart
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Spineart's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles